Sunrest Lifescience (NSE:SUNREST) ROCE %: 50.27% (As of Mar. 2026)


NSE:SUNREST Sunrest Lifescience Ltd NSE:SUNREST
41 GF Score
Price ₹35.05
! 5 Warning Signs
View Full Analysis

What is Sunrest Lifescience ROCE %?

Sunrest Lifescience NSE:SUNREST 41 ROCE % is 50.27% as of Mar. 2026. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sunrest Lifescience's annualized ROCE % for the quarter that ended in Mar. 2026 was 50.27%.

Sunrest Lifescience  (NSE:SUNREST) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sunrest Lifescience ROCE % Related Terms

Sunrest Lifescience ROCE % Historical Data

* Premium members only.

The historical data trend for Sunrest Lifescience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunrest Lifescience ROCE % Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 31.88 60.44 7.13 12.92 33.08

Sunrest Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only 63.00 -9.05 9.91 17.71 50.27
NSE:SUNREST
41GF Score
Sunrest Lifescience Ltd NSE:SUNREST
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunrest Lifescience ROCE % Calculation

Sunrest Lifescience's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=115.216/( ( (586.496 - 309.47) + (714.141 - 294.628) )/ 2 )
=115.216/( (277.026+419.513)/ 2 )
=115.216/348.2695
=33.08 %

Sunrest Lifescience's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=175.092/( ( (586.496 - 309.47) + (714.141 - 294.628) )/ 2 )
=175.092/( ( 277.026 + 419.513 )/ 2 )
=175.092/348.2695
=50.27 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 50.27% mean?
Sunrest Lifescience (NSE:SUNREST) has a ROCE % of 50.27% as of Mar. 2026.
Is Sunrest Lifescience's ROCE % too high?
Sunrest Lifescience's current ROCE % is 50.27%. The Healthcare Providers & Services industry median ROCE % is 6.43. Sunrest Lifescience's value of 50.27% is 681.8% above this industry median. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's ROCE % compare to competitors?
Sunrest Lifescience's ROCE % of 50.27% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. Sunrest Lifescience's value of 50.27% is 681.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current ROCE % of 50.27% is 681.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current ROCE % is 50.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current ROCE % of 50.27%. The current ROCE % is 50.27% and 681.8% above the Healthcare Providers & Services industry median of 6.43. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current ROCE % is 50.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunrest Lifescience Business Description

Address YMCA Club, Near SG Highway, D-608 West Gate, Near Brooklin Tower, Makarba, Jivraj Park, Ahmedabad, GJ, IND, 380051
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score

Get the complete analysis for NSE:SUNREST

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.05
Price